000520.KS KSC
Samil Pharmaceutical Co.,Ltd
1W: +6.2%
1M: +38.7%
3M: +27.4%
YTD: -21.2%
1Y: -13.6%
3Y: +16.4%
5Y: +0.1%
₩8,600.00 ($6.41)
+400.00 (+4.88%)
Weekly Expected Move ±8.2%
₩7186
₩7893
₩8600
₩9307
₩10014
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩183.8B ($136.9M)
52W Range5500-12860
Volume99,722
Avg Volume125,543
Beta0.34
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSeung Bum Huh
Employees585
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1985-05-28
Websitesamil-pharm.com
155 Hyoryeong-Ro
Seoul, SL
KR
Seoul, SL
KR
82 2 520 0300
About Samil Pharmaceutical Co.,Ltd
Samil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company founded in 1947 that develops, manufactures, and sells a range of healthcare products. While its portfolio includes various medicines and medical devices, it has a particular specialization in ophthalmology (eye care). The company engages in the development of new drugs and also provides Contract Development and Manufacturing Organisation (CDMO) services.
Latest News
No recent news
Recent Insider Trades
No insider trades found